Piramal Pharma Ltd Financials Statements

    Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

    Consolidate
    Standalone
    Financial Year
    Mar '25
    Dec '24
    Sep '24
    Jun '24
    Mar '24
    Total Qtr Revenue cr
    2,796.10
    2,216.35
    2,302.86
    1,970.68
    2,578.74
    Other Income Qtr Cr42.0312.1361.1119.5426.38
    Operating Revenues Qtr2,754.072,204.222,241.751,951.142,552.36

    *All values are in Cr.

    Operating Expenses Qtr
    2,193.08
    1,866.48
    1,900.14
    1,746.65
    2,022.43
    Operating Profit Qtr
    560.99
    337.74
    341.61
    204.49
    529.93
    EBITDA Qtr Cr
    603.02
    349.87
    402.72
    224.03
    525.79
    Depreciation Qtr
    242.76
    196.81
    192.22
    184.55
    196.13
    Net Profit Qtr
    153.50
    3.68
    22.59
    -88.64
    101.27
    Basic EPS Qtr
    1.16
    0.03
    0.17
    -0.67
    0.77
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -